https://ipharmag.com/article/vitamin-d-deficiency-belly-fat-death-risk iPharmag en 2026-08-16T05:52:16+00:00 Vitamin D Deficiency Plus Belly Fat May Be a Dangerous Combination, Study Finds https://ipharmag.com/article/rising-co2-blood-bicarbonate-shift iPharmag en 2026-08-16T05:52:16+00:00 A Large Study Detects a Subtle Shift in Human Blood as Atmospheric CO2 Rises https://ipharmag.com/article/opa1-brain-protein-fatty-food-overeating iPharmag en 2026-08-16T05:52:16+00:00 A Brain Protein May Help Explain Why We Overeat Fatty Foods &mdash; and Why Sex Matters https://ipharmag.com/article/gut-microbes-eat-mucus-low-fiber-diet iPharmag en 2026-08-16T05:52:16+00:00 Starve Your Gut Microbes of Fiber, and They May Start Eating You https://ipharmag.com/article/aligned-marketplace-primary-care-funding iPharmag en 2026-08-16T05:52:16+00:00 Aligned Marketplace Raises $20M to Connect Employers With Independent Primary-Care Doctors https://ipharmag.com/article/xanadu-quantum-photodynamic-cancer-therapy iPharmag en 2026-08-15T14:20:22+00:00 Xanadu and the University of Alberta Turn Quantum Computing on Light-Activated Cancer Drugs https://ipharmag.com/article/repligen-biolife-solutions-acquisition iPharmag en 2026-08-15T14:20:22+00:00 Repligen to Buy BioLife Solutions for $1.5B, Deepening the Cell-Therapy Supply Chain https://ipharmag.com/article/polyamines-iron-ferroptosis-anticancer iPharmag en 2026-08-15T14:20:22+00:00 A Surprising Job for Common Cell Molecules Points to a New Way to Kill Cancer https://ipharmag.com/article/gipr-brain-switch-obesity-weight-loss iPharmag en 2026-08-15T14:20:22+00:00 Scientists Explain a Brain Puzzle: Why Blocking <em>and</em> Activating One Receptor Both Aid Weight Loss https://ipharmag.com/article/estrogen-hormone-therapy-alzheimers-brain iPharmag en 2026-08-15T14:20:22+00:00 Women on Estrogen-Only Hormone Therapy Had Fewer Alzheimer&rsquo;s Signs in Their Brains https://ipharmag.com/article/zipalertinib-egfr-exon20-lung-cancer-phase3 iPharmag en 2026-08-14T04:39:01+00:00 Taiho and Cullinan&rsquo;s Lung Cancer Drug Aces a Phase 3 Trial, Heating Up a Crowded Race https://ipharmag.com/article/thermo-michael-j-fox-parkinsons-proteomics iPharmag en 2026-08-14T04:39:01+00:00 Thermo and the Michael J. Fox Foundation Map 5,500 Samples to Hunt Parkinson&rsquo;s Biomarkers https://ipharmag.com/article/ptc-sangamo-fabry-gene-therapy-acquisition iPharmag en 2026-08-14T04:39:01+00:00 PTC Buys a Fabry Disease Gene Therapy From Bankrupt Sangamo for Up to $211M https://ipharmag.com/article/omega-fatty-acids-nk-cells-cancer-lrp5 iPharmag en 2026-08-14T04:39:01+00:00 Could Omega Fatty Acids Blunt an Immune Cell&rsquo;s Cancer Defense? A Mouse Study Raises the Question https://ipharmag.com/article/fda-approves-zenbexus-iberdomide-celmod-myeloma iPharmag en 2026-08-14T04:39:01+00:00 FDA Approves Bristol Myers&rsquo; Zenbexus, the First of a New Class of Myeloma Drugs